News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
KUBACKI RAYMOND C JR
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/24/2023 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 1,500 shares
@ $4.93, valued at
$7.4k
|
|
| 05/16/2023 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 1,725 shares
@ $4.87, valued at
$8.4k
|
|
| 02/14/2023 |
SC 13G/A
| KUBACKI RAYMOND C JR reports a 6.5% stake in Psychemedics Corporation |
| 11/15/2022 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 2,625 shares
@ $6.18, valued at
$16.2k
|
|
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
SC 13G/A
| KUBACKI RAYMOND C JR reports a 6% stake in Psychemedics Corporation. |
| 11/16/2021 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 3,062 shares
@ $8.5, valued at
$26k
|
|
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/08/2020 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Bought 1,000 shares
@ $5, valued at
$5k
|
|
| 11/12/2020 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Bought 1,000 shares
@ $3.93, valued at
$3.9k
Bought 1,000 shares
@ $3.79, valued at
$3.8k
|
|
| 11/12/2020 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 35,000 shares
@ $0
Granted 15,000 options to buy
@ $4.07, valued at
$61.1k
|
|
| 06/17/2019 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Bought 1,000 shares
@ $9.99, valued at
$10k
|
|
| 05/07/2019 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 60,000 options to buy
@ $10.6, valued at
$636k
|
|
| 05/02/2019 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 1,051 shares
@ $11.6, valued at
$12.2k
|
|
| 05/10/2018 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 957 shares
@ $20.21, valued at
$19.3k
|
|
| 05/10/2018 |
4/A
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 846 shares
@ $21.06, valued at
$17.8k
|
|
| 05/07/2018 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 28,000 options to buy
@ $21.04, valued at
$589.1k
|
|
| 05/02/2018 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 846 shares
@ $21.06, valued at
$17.8k
|
|
| 11/15/2017 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Bought 1,000 shares
@ $16.88, valued at
$16.9k
|
|
| 05/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/24/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/16/2016 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 42,000 options to buy
@ $13.82, valued at
$580.4k
|
|
| 05/11/2016 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 1,054 shares
@ $14.02, valued at
$14.8k
|
|
| 05/04/2016 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 921 shares
@ $14.41, valued at
$13.3k
|
|
| 02/11/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/30/2013 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 1,548 shares
@ $11.4, valued at
$17.6k
Paid exercise price by delivering 1,793 shares
@ $11.47, valued at
$20.6k
|
|
| 05/28/2013 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 17,000 shares
@ $0 |
|
| 04/24/2013 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 2,421 shares
@ $11.76, valued at
$28.5k
|
|
| 05/29/2012 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 1,494 shares
@ $9.74, valued at
$14.6k
|
|
|
|
|